Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DB25FPKXS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,892
Award facts
- Contract value 100% obligated
- $24,891.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,891.86 to AmerisourceBergen Drug Corp for KISQALI 400 mg daily dose tablets (42-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. KISQALI is a prescription medication used in oncology treatment, and this delivery order represents a single transaction fulfilling federal medical supply requirements through AmerisourceBergen's established procurement relationship with the Defense Logistics Agency.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen leverages this flexible contract framework to deliver specialized medical commodities to customers including the Defense Health Agency and other government healthcare systems across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FPKXS?
SPE2DB25FPKXS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FPKXS worth?
The government has obligated $24,892 on SPE2DB25FPKXS.
Is contract SPE2DB25FPKXS an order under another contract?
Yes. SPE2DB25FPKXS is a delivery order under SPE2DB25D3109, an indefinite delivery contract.
Was contract SPE2DB25FPKXS competed?
The extent of competition for SPE2DB25FPKXS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award